1 – 10 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
- Contribution to journal › Article
- 2025
-
Mark
Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study
- Contribution to journal › Article
-
Mark
Fusions4U: a resource of validated and annotated gene fusions in 328 cancer cell lines
(2025) In BMC Cancer
- Contribution to journal › Article
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
- Contribution to journal › Article
-
Mark
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
- Contribution to journal › Article
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
- Contribution to journal › Article
-
Mark
Navigating Immune Landscapes in Ovarian Cancer - Spatial and Genomic Insights into High-Grade Serous and Endometriosis-Associated Histotypes
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation
- Thesis › Doctoral thesis (compilation)
-
Mark
Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
- Contribution to journal › Article
